X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-19 | ECBK | Ecb Bancorp, Inc. /Md/ | Lavertu Brandon | CFO | P - Purchase | $13.97 | +5,000 | 106,072 | +5% | +$69,857 | |||||
2024-09-19 | JEF | Jefferies Financial Group Inc. | Sumitomo Mitsui Financial Group, Inc. | Dir | P - Purchase | $59.67 | +9,247,081 | 9,247,081 | New | +$551,773,323 | ||||||
2024-09-18 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $0.75 | +125,000 | 11,440,865 | +1% | +$93,750 | ||||||
| M | 2024-09-17 | CULP | Culp Inc | English Aron R. | 10% | P - Purchase | $6.09 | +240,047 | 1,595,840 | +18% | +$1,461,583 | |||||
2024-09-18 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $3.16 | +61,000 | 7,585,000 | +1% | +$192,992 | ||||||
| A | 2024-09-18 | FCUV | Focus Universal Inc. | Lee Edward Shihai | Dir, 10% | P - Purchase | $0.30 | +1,000,000 | 9,185,000 | +12% | +$300,000 | |||||
2024-09-18 | MPW | Medical Properties Trust Inc | Pitman Elizabeth N | Dir | P - Purchase | $6.01 | +8,087 | 76,740 | +12% | +$48,603 | ||||||
| M | 2024-09-17 | GTE | Gran Tierra Energy Inc. | Guidry Gary | Pres, CEO | P - Purchase | $6.17 | +100,000 | 525,672 | +23% | +$617,000 | |||||
| DM | 2024-09-17 | ECBK | Ecb Bancorp, Inc. /Md/ | Citrano John A | EVP, COO | P - Purchase | $13.54 | +9,650 | 123,166 | +9% | +$130,656 | |||||
2024-09-18 | GLP | Global Partners LP | Global Gp LLC | General Partner | P - Purchase | $44.02 | +5,000 | 266,081 | +2% | +$220,100 | ||||||
| M | 2024-09-17 | TALK | Talkspace, Inc. | Harris Ian Jiro | CFO | P - Purchase | $2.12 | +70,100 | 397,657 | +21% | +$148,566 | |||||
2024-09-19 | YEXT | Yext, Inc. | Waugh Seth H. | Dir | P - Purchase | $6.65 | +32,600 | 153,350 | +27% | +$216,647 | ||||||
2024-09-18 | MEI | Methode Electronics Inc | Blom David P | Dir | P - Purchase | $10.81 | +9,320 | 37,531 | +33% | +$100,749 | ||||||
| D | 2024-09-19 | YHNAU | Yhn Acquisition I Ltd | Yhn Partners I Ltd | 10% | P - Purchase | $10.00 | +250,000 | 1,850,000 | +16% | +$2,500,000 | |||||
2024-09-18 | EPSN | Epsilon Energy Ltd. | Stabell Jason | CEO | P - Purchase | $5.05 | +74,000 | 573,847 | +15% | +$373,700 | ||||||
2024-09-18 | EPSN | Epsilon Energy Ltd. | Williamson Andrew | CFO | P - Purchase | $5.05 | +50,000 | 88,128 | +131% | +$252,500 | ||||||
| M | 2024-09-18 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.30 | +50,000 | 8,050,000 | +1% | +$65,000 | |||||
| M | 2024-09-17 | FRD | Friedman Industries Inc | Taylor Mike J | Pres , CEO , Dir | P - Purchase | $13.94 | +2,500 | 162,154 | +2% | +$34,851 | |||||
| M | 2024-09-17 | RPHM | Reneo Pharmaceuticals, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.36 | +56,106 | 4,379,818 | +1% | +$76,237 | |||||
2024-09-18 | FRD | Friedman Industries Inc | Reichenthal Max Alan | Dir | P - Purchase | $14.00 | +2,000 | 30,761 | +7% | +$28,000 | ||||||
2024-09-18 | SRBK | Sr Bancorp, Inc. | Lebovitz Marc | Dir | P - Purchase | $10.75 | +9,800 | 30,500 | +47% | +$105,350 | ||||||
| M | 2024-09-17 | BMEZ | Blackrock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% | P - Purchase | $15.91 | +47,682 | 20,586,113 | 0% | +$758,548 | |||||
| M | 2024-09-17 | BIGZ | Blackrock Innovation & Growth Term Trust | Saba Capital Management, L.P. | 10% | P - Purchase | $7.46 | +465,998 | 55,339,170 | +1% | +$3,474,968 | |||||
| M | 2024-09-16 | IBO | Impact Biomedical Inc. | Dss, Inc. | 10% | P - Purchase | $2.65 | +57,800 | 1,736,482 | +3% | +$153,220 | |||||
| D | 2024-09-18 | WSC | Willscot Holdings Corp | Soultz Bradley Lee | CEO | P - Purchase | $38.97 | +5,000 | 715,287 | +1% | +$194,855 | |||||
2024-09-18 | FCUV | Focus Universal Inc. | Wang Desheng | CEO, Dir, 10% | P - Purchase | $0.30 | +1,000,000 | 22,729,550 | +5% | +$300,000 | ||||||
2024-09-18 | FCUV | Focus Universal Inc. | Lee Edward Shihai | Pres, Dir, 10% | P - Purchase | $0.30 | +1,000,000 | 9,185,000 | +12% | +$300,000 | ||||||
2024-09-13 | ASLE | Aersale Corp | Finazzo Nicolas | See Remarks | P - Purchase | $5.36 | +20,000 | 4,624,767 | 0% | +$107,122 | ||||||
| D | 2024-09-16 | BCAX | Bicara Therapeutics Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $18.00 | +1,833,000 | 2,652,575 | +224% | +$32,994,000 | |||||
| D | 2023-09-07 | PROP | Prairie Operating Co. | Wallis James W. | 10% | P - Purchase | $3.05 | +204,422 | 2,250,486 | +10% | +$623,487 | |||||
| M | 2024-09-16 | OMIC | Singular Genomics Systems, Inc. | Tang Kevin | 10% | P - Purchase | $14.75 | +122,416 | 372,000 | +49% | +$1,806,220 | |||||
2024-09-16 | TAKAX | Carlyle Tactical Private Credit Fund | Securian Asset Management, Inc | 10% | P - Purchase | $25.00 | +544,000 | 1,464,000 | +59% | +$13,600,000 | ||||||
| AM | 2023-08-16 | FRZA | Forza X1, Inc. | Visconti Joseph C | Exec COB, CPO, 10% | P - Purchase | $1.00 | +50,000 | 1,785,000 | +3% | +$50,000 | |||||
| D | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Enavate Sciences Gp, LLC | 10% | P - Purchase | $17.00 | +882,353 | 3,761,359 | +31% | +$15,000,001 | |||||
| A | 2022-12-08 | FRZA | Forza X1, Inc. | Visconti Joseph C | Exec COB, 10% | P - Purchase | $1.44 | +20,000 | 1,735,000 | +1% | +$28,700 | |||||
| M | 2024-09-16 | PMN | Promis Neurosciences Inc. | Gordon Michael S | 10% | P - Purchase | $1.25 | +93,223 | 2,217,185 | +4% | +$116,880 | |||||
2024-09-16 | PSEC | Prospect Capital Corp | Eliasek M Grier | COO | P - Purchase | $5.50 | +5,000 | 1,666,130 | 0% | +$27,500 | ||||||
2024-09-16 | CIA | Citizens, Inc. | Stenberg Jon | Pres, CEO | P - Purchase | $2.99 | +11,934 | 107,487 | +12% | +$35,683 | ||||||
2024-09-18 | SRBK | Sr Bancorp, Inc. | Lupo Thomas | Dir | P - Purchase | $10.58 | +5,000 | 20,000 | +33% | +$52,885 | ||||||
2024-09-17 | RA | Brookfield Real Assets Income Fund Inc. | Guichard Justin Charles | Portfolio Manager | P - Purchase | $13.58 | +7,364 | 7,364 | New | +$99,996 | ||||||
2024-09-16 | TAKIX | Carlyle Tactical Private Credit Fund | Principal Life Insurance Co | 10% | P - Purchase | $25.00 | +400,000 | 2,400,000 | +20% | +$10,000,000 | ||||||
2024-09-16 | NAGRX | Niagara Income Opportunities Fund | Ball George Bradley | Founder and MM of Adviser, 10% | P - Purchase | $10.49 | +9,533 | 19,533 | +95% | +$100,000 | ||||||
2024-09-16 | DNLIX | Denali Structured Return Strategy Fund | Ball George Bradley | Founder and MM of Adviser, 10% | P - Purchase | $10.94 | +9,141 | 19,141 | +91% | +$100,000 | ||||||
2024-09-17 | HCWC | Healthy Choice Wellness Corp. | Holman Jeffrey Elliot | CEO | P - Purchase | $10.00 | +10,000 | 1,089,410 | +1% | +$100,000 | ||||||
2024-09-17 | HCWC | Healthy Choice Wellness Corp. | Ollet John | CFO | P - Purchase | $10.00 | +10,000 | 388,176 | +3% | +$100,000 | ||||||
2024-09-17 | HCWC | Healthy Choice Wellness Corp. | Santi Christopher | Pres | P - Purchase | $10.00 | +5,000 | 584,488 | +1% | +$50,000 | ||||||
2024-09-17 | FRZA | Forza X1, Inc. | Schuyler Kevin | Dir | P - Purchase | $0.30 | +90,668 | 100,000 | +972% | +$27,200 | ||||||
2024-09-13 | VRDN | Viridian Therapeutics, Inc.de | Fairmount Funds Management LLC | Dir, 10% | P - Purchase | $18.75 | +1,600,000 | 3,445,813 | +87% | +$30,000,000 | ||||||
| AD | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Fairmount Funds Management LLC | Dir | P - Purchase | $17.00 | +300,000 | 1,892,806 | +19% | +$5,100,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Mathers Edward T | Dir, 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Baskett Forest | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Behbahani Ali | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Chang Carmen | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Walker Paul Edward | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Yang Rick | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Sandell Scott D | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $16.00 | +750,000 | 3,812,215 | +24% | +$12,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | New Enterprise Associates 17, L.P. | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Frazier Life Sciences X, L.P. | 10% | P - Purchase | $16.00 | +625,000 | 4,552,774 | +16% | +$10,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Heron Patrick J | Dir, 10% | P - Purchase | $16.00 | +625,000 | 4,552,774 | +16% | +$10,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Aynechi Tiba | Dir | P - Purchase | $16.00 | +750,000 | 2,136,335 | +54% | +$12,000,000 | |||||
| D | 2024-09-16 | MBX | Mbx Biosciences, Inc. | Gordon Carl L | Dir, 10% | P - Purchase | $16.00 | +750,000 | 3,812,215 | +24% | +$12,000,000 | |||||
2024-09-13 | ZBIO | Zenas Biopharma, Inc. | Lu Hongbo | Dir | P - Purchase | $17.00 | +58,823 | 58,823 | New | +$999,991 | ||||||
2024-09-12 | TERN | Terns Pharmaceuticals, Inc. | Lu Hongbo | Dir | P - Purchase | $10.50 | +476,190 | 476,190 | New | +$4,999,995 | ||||||
| M | 2024-09-13 | APPN | Appian Corp | Abdiel Capital Advisors, LP | 10% | P - Purchase | $33.07 | +20,223 | 20,198,853 | 0% | +$668,675 | |||||
2024-09-06 | SBUX | Starbucks Corp | Knudstorp Jorgen Vig | Dir | P - Purchase | $91.50 | +380 | 36,242 | +1% | +$34,770 | ||||||
| D | 2024-09-17 | BCAX | Bicara Therapeutics Inc. | Flynn James E | Possible Members of 10% Group, 10% | P - Purchase | $18.00 | +70,000 | 1,795,174 | +4% | +$1,260,000 | |||||
2024-09-06 | HNRG | Hallador Energy Co | Wesley Charles Ray IV | Dir | P - Purchase | $5.97 | +25,000 | 275,572 | +10% | +$149,265 | ||||||
2024-09-16 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
| M | 2024-09-13 | GLP | Global Partners LP | Global Gp LLC | General Partner | P - Purchase | $43.07 | +12,100 | 261,081 | +5% | +$521,110 | |||||
2024-08-20 | QTRX | Quanterix Corp | Walt David R | Dir | P - Purchase | $13.29 | +47,000 | 1,487,342 | +3% | +$624,630 | ||||||
2024-09-16 | BJ | Bj'S Wholesale Club Holdings, Inc. | Ortega Steven L | Dir | P - Purchase | $81.26 | +2,455 | 6,901 | +55% | +$199,493 | ||||||
| AM | 2024-09-10 | GLP | Global Partners LP | Global Gp LLC | General Partner | P - Purchase | $43.52 | +9,800 | 248,981 | +4% | +$426,466 | |||||
2024-09-13 | PSEC | Prospect Capital Corp | Eliasek M Grier | COO | P - Purchase | $5.44 | +5,000 | 1,661,130 | 0% | +$27,200 | ||||||
2024-09-13 | SRBK | Sr Bancorp, Inc. | Lebovitz Marc | Dir | P - Purchase | $10.15 | +10,200 | 20,700 | +97% | +$103,506 | ||||||
| A | 2024-09-16 | MERC | Mercer International Inc. | Bueno Estrada Juan Carlos | CEO, Pres | P - Purchase | $6.70 | +7,800 | 67,615 | +13% | +$52,260 | |||||
| D | 2024-09-16 | USCB | Uscb Financial Holdings, Inc. | Rodriguez Ramon A | Dir | P - Purchase | $14.61 | +6,000 | 12,000 | +100% | +$87,660 | |||||
2024-09-16 | BIGZ | Blackrock Innovation & Growth Term Trust | Saba Capital Management, L.P. | 10% | P - Purchase | $7.33 | +31,631 | 54,873,172 | 0% | +$231,855 | ||||||
2024-09-16 | GECC | Great Elm Capital Corp. | Drapkin Matthew A | Dir | P - Purchase | $9.92 | +9,600 | 874,187 | +1% | +$95,236 | ||||||
2024-09-13 | BRCC | Brc Inc. | Welling Glenn W. | Dir, 10% | P - Purchase | $3.17 | +684,542 | 14,163,176 | +5% | +$2,169,998 | ||||||
2024-09-13 | MTDR | Matador Resources Co | Baty Robert Gaines | Dir | P - Purchase | $50.58 | +500 | 67,617 | +1% | +$25,290 | ||||||
2024-09-12 | XCUR | Exicure, Inc. | Dgp Co., Ltd. | 10% | P - Purchase | $3.00 | +237,223 | 849,223 | +39% | +$711,669 | ||||||
2024-09-13 | CTLP | Cantaloupe, Inc. | Venkatesan Ravi | CEO | P - Purchase | $6.30 | +8,000 | 136,658 | +6% | +$50,400 | ||||||
| DE | 2024-09-13 | ISPO | Inspirato Inc | One Planet Group LLC | 10% | P - Purchase | $3.43 | +1,580,180 | 2,795,451 | +130% | +$5,420,020 | |||||
| DE | 2024-09-13 | ISPO | Inspirato Inc | Zamani Payam | CEO, 10% | P - Purchase | $3.43 | +1,580,180 | 3,795,451 | +71% | +$5,420,020 | |||||
| D | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Enright Patrick G | Dir | P - Purchase | $17.00 | +440,000 | 774,530 | +132% | +$7,480,000 | |||||
| D | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Nunn Jason Raleigh | Dir | P - Purchase | $17.00 | +882,352 | 3,056,801 | +41% | +$14,999,984 | |||||
| D | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Fairmount Funds Management LLC | Dir | P - Purchase | $17.00 | +300,000 | 1,604,891 | +23% | +$5,100,000 | |||||
| D | 2024-09-16 | ZBIO | Zenas Biopharma, Inc. | Sr One Capital Management, LLC | 10% | P - Purchase | $17.00 | +2,235,294 | 4,911,539 | +84% | +$37,999,998 | |||||
| D | 2024-09-12 | INMB | Inmune Bio, Inc. | Tesi Raymond Joseph | Pres, CEO, 10% | P - Purchase | $6.38 | +15,380 | 1,554,106 | +1% | +$98,048 | |||||
| D | 2024-09-12 | INMB | Inmune Bio, Inc. | Moss David J | CFO, 10% | P - Purchase | $6.38 | +7,690 | 1,275,869 | +1% | +$49,024 | |||||
2024-09-13 | WY | Weyerhaeuser Co | O'Rourke James Calvin | Dir | P - Purchase | $32.01 | +7,800 | 17,672 | +79% | +$249,676 | ||||||
2024-09-12 | SER | Serina Therapeutics, Inc. | Mintz Steven | Dir | P - Purchase | $6.47 | +6,000 | 38,230 | +19% | +$38,814 | ||||||
2024-09-13 | MERC | Mercer International Inc. | Bueno Estrada Juan Carlos | CEO, Pres | P - Purchase | $6.60 | +7,800 | 67,615 | +13% | +$51,480 | ||||||
2024-09-12 | AMLX | Amylyx Pharmaceuticals, Inc. | Frates James M | CFO | P - Purchase | $2.53 | +40,000 | 259,995 | +18% | +$101,368 | ||||||
2024-09-13 | VTS | Vitesse Energy, Inc. | Gerrity Robert W | CEO | P - Purchase | $24.73 | +10,000 | 1,633,340 | +1% | +$247,300 | ||||||
2024-09-16 | NWPP | New Peoples Bankshares Inc | Long Barton Scot | Dir | P - Purchase | $2.68 | +12,450 | 129,842 | +11% | +$33,366 | ||||||
2024-09-16 | NWPP | New Peoples Bankshares Inc | Cox John D | Dir | P - Purchase | $2.68 | +12,450 | 679,639 | +2% | +$33,366 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |